bl-8040
Showing 1 - 9 of 9
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
- BL-8040
- Nelarabine
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome Trial in Houston (BL-8040, horse anti-thymocyte globulin (hATG),
Completed
- Aplastic Anemia
- Hypoplastic Myelodysplastic Syndrome
- BL-8040
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 28, 2020
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil
Recruiting
- Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
- 5-Fluorouracil (5-FU)
- +11 more
-
Scottsdale, Arizona
- +41 more
Jan 19, 2023
Chronic Myeloid Leukemia Trial in Tel-Hashomer (BL-8040)
Withdrawn
- Chronic Myeloid Leukemia
- BL-8040
-
Tel-Hashomer, IsraelChaim Sheba Medical Center
Aug 11, 2016
Acute Myeloid Leukemia Trial in Halle (Cytarabine, BL-8040, Placebo (for BL-8040))
Unknown status
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
-
Halle, GermanyUniveritätsklinikum Halle, Klinik Innere Medizin 4
Sep 18, 2015
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB) Trial in Jerusalem (BL-8040, Placebo)
Completed
- Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
- BL-8040
- Placebo
-
Jerusalem, IsraelHadassah Clinical Research Center
Jul 30, 2015